Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Oguro

Showing results (11-20 of 74) with videos related to

Pageof 8
Sort By:
Nucleic Acids Research|October 10, 1979
The mode of inhibitory action by pyridoxal 5-phosphate on DNA polymerase-alpha and -betaM Oguro, H Nagano, Y Mano
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1984
[Combination chemotherapy of N(4)-behenoyl-1-beta-arabinofuranosylcytosine, aclarubicin, 6-MP, and prednisolone (BH-AC. AMP therapy) for adult acute non-lymphocytic leukemia]K Ishige, T Takagi, M Oguro
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1984
[Antitumor activity of a new nitrosourea, MCNU, on a cellular morphological basis evaluated by a new in vitro antitumor sensitivity assay]M Oguro, T Yanagawa, K Takenaga
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1988
[Biological function of DNA topoisomerases and its implication in cancer chemotherapy]T Andoh, K Okada, M Oguro
Japanese Journal of Cancer Research : Gann|February 1, 1985
Dynamic analysis of changing features of tumor cells incubated with antitumor agents in vitro and its application for predictive activity assay of antitumor agentsM Oguro, T Takagi, K Takenaga
Cancer Letters|June 10, 1998
4-Piperidinopiperidine-resistant lymphoma cells were resistant to dexamethasone- and A23187-induced apoptosisY Onishi, M Oguro, H Kizaki
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1993
[Alternating CHOP-MEVP chemotherapy for advanced-stage, intermediate- and high-grade non-Hodgkin's lymphomas]T Takagi, C Sakai, M Oguro
Japanese Journal of Clinical Oncology|June 1, 1989
Intermediate-dose cytosine arabinoside in the treatment of recurrent or refractory non-Hodgkin's lymphomaT Takagi, C Sakai, M Oguro
Oncology|January 1, 1990
Combination chemotherapy with pirarubicin (THP), cyclophosphamide, vincristine, and prednisolone (VEP-THP therapy) in the treatment of non-Hodgkin's lymphomaT Takagi, C Sakai, M Oguro
Journal of Virology|October 1, 1986
Identification of coding regions for various Epstein-Barr virus-specific antigens by gene transfer and serologyK Takada, N Shimizu, M Oguro, et al.
Pageof 8

Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
Nucleic Acids Research|October 10, 1979
The mode of inhibitory action by pyridoxal 5-phosphate on DNA polymerase-alpha and -betaM Oguro, H Nagano, Y Mano
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1984
[Combination chemotherapy of N(4)-behenoyl-1-beta-arabinofuranosylcytosine, aclarubicin, 6-MP, and prednisolone (BH-AC. AMP therapy) for adult acute non-lymphocytic leukemia]K Ishige, T Takagi, M Oguro
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1984
[Antitumor activity of a new nitrosourea, MCNU, on a cellular morphological basis evaluated by a new in vitro antitumor sensitivity assay]M Oguro, T Yanagawa, K Takenaga
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1988
[Biological function of DNA topoisomerases and its implication in cancer chemotherapy]T Andoh, K Okada, M Oguro
Japanese Journal of Cancer Research : Gann|February 1, 1985
Dynamic analysis of changing features of tumor cells incubated with antitumor agents in vitro and its application for predictive activity assay of antitumor agentsM Oguro, T Takagi, K Takenaga
Cancer Letters|June 10, 1998
4-Piperidinopiperidine-resistant lymphoma cells were resistant to dexamethasone- and A23187-induced apoptosisY Onishi, M Oguro, H Kizaki
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1993
[Alternating CHOP-MEVP chemotherapy for advanced-stage, intermediate- and high-grade non-Hodgkin's lymphomas]T Takagi, C Sakai, M Oguro
Japanese Journal of Clinical Oncology|June 1, 1989
Intermediate-dose cytosine arabinoside in the treatment of recurrent or refractory non-Hodgkin's lymphomaT Takagi, C Sakai, M Oguro
Oncology|January 1, 1990
Combination chemotherapy with pirarubicin (THP), cyclophosphamide, vincristine, and prednisolone (VEP-THP therapy) in the treatment of non-Hodgkin's lymphomaT Takagi, C Sakai, M Oguro
Journal of Virology|October 1, 1986
Identification of coding regions for various Epstein-Barr virus-specific antigens by gene transfer and serologyK Takada, N Shimizu, M Oguro, et al.
Pageof 8